Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-06-23

Clinical Trial Update: Small Doses of Dexmedetomidine for Emergence Agitation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating small doses of dexmedetomidine for emergence agitation after anesthesia. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Emergence Agitation | Phase 4 | Status: UNKNOWN